Clinical Trial Update: Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating mesenchymal stem cells for treating poor graft function after an allogeneic hematopoietic stem cell transplant; the status of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Diseases
• Poor Graft Function

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Stem Cell Transplantation, Hematopoietic, Mesenchymal Stem Cells | Phase 2 | Status: UNKNOWN